| Protocol    | Indication   | AI_Indication_v2   | Drug_or_biologic   | Test_article                    | Pages   | AI_phase   | AI_phase_v2   | Rev_phase   | AI_SAP   | AI_SAP_v2   | Rev_SAP      | CTGov_SAP   | AI_effect   | AI_effect_v2   | Rev_effect     | AI_N   | AI_N_v2   | Rev_N   | CTGov_N   | AI_sim   | AI_sim_v2   | Rev_sim   | AI_risk   | Rev_risk   | Rev_arms   | AI_arms_v2   | Rev_countries                                   | AI_countries_v2   | CTGov_countries                                 | is_country_exact_match   | is_country_approximate_match   |
|:------------|:-------------|:-------------------|:-------------------|:--------------------------------|:--------|:-----------|:--------------|:------------|:---------|:------------|:-------------|:------------|:------------|:---------------|:---------------|:-------|:----------|:--------|:----------|:---------|:------------|:----------|:----------|:-----------|:-----------|:-------------|:------------------------------------------------|:------------------|:------------------------------------------------|:-------------------------|:-------------------------------|
| NCT00752856 | HIV          | HIV                | drug               | raltegravir_lopinavir_ritonavir | 57      | 1          | 2.0           | 2           | no       | 1           | 3pp in prot  | 1           | yes         | 1              | yes Sec. 9.3   | 50     | 50        | 51      | 51.0      | no       | 0           | no        | high      | high       | 2          | 2            | US                                              | CA,US             | US                                              | 0                        | 0                              |
| NCT01896921 | HIV          | HIV                | drug               | maraviroc_integrase_inhib       | 29      | 3          | 3.0           | 3           | no       | 1           | 0.5p in prot | 1           | no          | 0              | no             | 44     | 30        | 30      | 7.0       | no       | 0           | no        | high      | high       | 1          | 1            | US                                              | US                | US                                              | 1                        | 1                              |
| NCT01933594 | HIV          | HIV                | drug               | romidepsin                      | 140     | 1          | 1.5           | 1/2         | no       | 1           | 9pp in prot  | 0           | no          | 1              | yes Sec. 9.4.2 | 60     | 60        | 59      | 59.0      | no       | 0           | no        | high      | low        | 8          | 3            | US                                              | US,XX             | US                                              | 0                        | 0                              |
| NCT02217904 | HIV          | HIV                | drug               | islatravir                      | 114     | 1          | 1.0           | 1           | yes      | 0           | 4pp in prot  | 1           | no          | 1              | yes Sec. 8.1ff | 42     | 42        | 30      | 30.0      | no       | 0           | no        | med       | low        | 1          | 1            | DE                                              | CA,US,XX          | DE                                              | 0                        | 0                              |
| NCT02263326 | HIV          | HIV                | drug               | dolutegravir_lamivudin          | 47      | 0          | 2.0           | 3           | no       | 1           | 2pp in prot  | 1           | yes         | 1              | yes Sec. 9.4   | 90     | 90        | 89      | 89.0      | no       | 0           | no        | nan       | med        | 2          | 2            | US                                              | US                | US                                              | 1                        | 1                              |
| NCT02707861 | HIV          | HIV                | biologic           | ibalizumab                      | 106     | 3          | 3.0           | 3           | no       | 0           | 3pp in prot  | 0           | no          | 0              | yes Sec. 9.8   | 100    | 100       | 79      | 79.0      | no       | 0           | no        | high      | med        | 2          | 2            | US,PR                                           | TW,US,XX          | US,PR                                           | 0                        | 0                              |
| NCT02788175 | HIV          | HIV                | biologic           | vedolizumab                     | 55      | 3          | 1.0           | 1           | no       | 1           | 2pp in prot  | 1           | no          | 0              | yes Sec. 13    | 52     | 20        | 26      | 26.0      | no       | 0           | no        | high      | med        | 1          | 1            | US                                              | US                | US                                              | 1                        | 1                              |
| NCT02946047 | HIV          | HIV                | drug               | ixazomib                        | 83      | 1          | 1.5           | 1/2         | no       | 1           | 2pp in prot  | 1           | no          | 0              | no             | 49     | 17        | 17      | 17.0      | no       | 0           | no        | high      | high       | 4          | 1            | US                                              | US                | US                                              | 1                        | 1                              |
| NCT03262441 | HIV          | HIV                | drug               | mycophenolate_mofetil           | 39      | 2          | 2.0           | 2           | no       | 1           | 1p in prot   | 1           | no          | 1              | yes Sec. 8.4.1 | 450    | 10        | 5       | 5.0       | no       | 0           | no        | high      | high       | 1          | 1            | US                                              | US                | US                                              | 1                        | 1                              |
| NCT03351699 | HIV          | HIV                | drug               | MK-4250                         | 87      | 1          | 1.0           | 1           | no       | 0           | 1p in prot   | 1           | no          | 1              | yes Sec. 8.1ff | 900    | 30        | 24      | 24.0      | no       | 0           | no        | high      | med        | 5          | 3            | DE                                              | CA,HT,JE,US,XX    | DE                                              | 0                        | 0                              |
| NCT02342886 | TB           | TB                 | drug               | moxifloxacin                    | 112     | 2          | 3.0           | 3           | no       | 0           | 4pp in prot  | 0           | yes         | 1              | yes Sec. 8.3   | 1200   | 1200      | 284     | 284.0     | no       | 0           | no        | med       | med        | 5          | 2            | GE,KE,MY,PH,ZA,TZ,UG,ZM,BR,CN,HT,MZ,PE,RU,TH,UA | CA,CH,GB,US,XX    | GE,KE,MY,PH,ZA,TZ,UG,ZM,BR,CN,HT,MZ,PE,RU,TH,UA | 0                        | 0                              |
| NCT02153528 | TB           | TB                 | drug               | rifampicin                      | 54      | 1          | 1.0           | 3           | no       | 1           | 2pp in prot  | 0           | no          | 1              | yes Sec. 8.4   | 500    | 500       | 1000    | 701.0     | no       | 0           | no        | high      | med        | 2          | 2            | BD                                              | BD,BE             | BD                                              | 0                        | 0                              |
| NCT02583048 | TB           | TB                 | drug               | bedaquiline_delamanid           | 119     | 2          | 2.0           | 2           | no       | 1           | 8pp in prot  | 0           | yes         | 1              | yes Sec. 9.4   | 84     | 84        | 84      | 84.0      | yes      | 1           | no        | med       | low        | 3          | 3            | PE,ZA                                           | US,XX,ZA          | PE,ZA                                           | 0                        | 0                              |
| NCT02193776 | TB           | TB                 | drug               | bedaquiline_moxifloxacin        | 112     | 2          | 2.0           | 2           | no       | 0           | 3pp in prot  | 0           | yes         | 1              | yes Sec. 8.2   | 240    | 240       | 240     | 240.0     | no       | 0           | no        | med       | med        | 3          | 3            | ZA,TZ,UG                                        | MX,US,XX,ZA       | ZA,TZ,UG                                        | 0                        | 0                              |
| NCT02410772 | TB           | TB                 | drug               | rifapentine_moxifloxacin        | 248     | 3          | 3.0           | 3           | yes      | 1           | 3pp in prot  | 1           | yes         | 1              | yes Sec. 13.6  | 90     | 90        | 2500    | 2516.0    | no       | 1           | no        | low       | low        | 3          | 1            | US,BR,CN,HT,IN,KE,MW,PE,ZA,TH,UG,VN,ZW,ES       | US                | US,BR,CN,HT,IN,KE,MW,PE,ZA,TH,UG,VN,ZW,ES       | 0                        | 0                              |
| NCT02114684 | TB           | TB                 | drug               | moxifloxacin                    | 58      | 2          | 2.0           | 1/2         | no       | 1           | 2pp in prot  | 0           | yes         | 1              | yes Sec. 9.1   | 330    | 330       | 330     | 197.0     | yes      | 1           | no        | low       | low        | 2          | 2            | ZA                                              | US,ZA             | ZA                                              | 0                        | 0                              |
|             |              |                    |                    |                                 |         |            |               |             |          |             |              |             |             |                |                |        |           |         |           |          |             |           |           |            |            |              |                                                 |                   |                                                 |                          |                                |
| ACCURACY    |              |                    |                    |                                 |         | 0.5        | 0.6875        |             | 0.3125   | 0.625       |              |             | 0.5625      | 0.875          |                | 0.1875 | 0.3125    |         |           |          |             |           |           |            |            | 0.6875       |                                                 | 0.3125            |                                                 |                          | 0.3125                         |
# Hutchinson dataset

| NCT         | Disease   | Intervention   | Outcome   | Sponsor   | Status                 | Phase   | Actual_Enroll   | Anticipated_Enroll   | CTGov_countries                                                                                                      | CTGov_SAP   | CTGov_N   | Informative   | Informative_Condition_Not_Met   | is_include   | file_name                                                                                                                                               | AI_Indication_v2   | AI_phase_v2   | AI_arms_v2   | AI_SAP_v2   | AI_N_v2   | AI_effect_v2   | AI_sim_v2   | AI_countries_v2   | AI_risk_v2   | AI_risk_label_v2    |
|:------------|:----------|:---------------|:----------|:----------|:-----------------------|:--------|:----------------|:---------------------|:---------------------------------------------------------------------------------------------------------------------|:------------|:----------|:--------------|:--------------------------------|:-------------|:--------------------------------------------------------------------------------------------------------------------------------------------------------|:-------------------|:--------------|:-------------|:------------|:----------|:---------------|:------------|:------------------|:-------------|:--------------------|
| NCT00946712 | LUNG      | Drug           | Clinical  | Other     | Active, Not Recruiting | 3.0     | 1333            | 1546                 | US,MX                                                                                                                | 1.0         | 1333.0    | 0             | Design                          | True         | ../data/ctgov/json/12_NCT00946712_Prot_SAP_000.pdf.json                                                                                                 | HIV                | 3.0           | 1            | 1           | 40        | 1              | 1           | CA,US             | 72           | LOW                 |
| NCT01032629 | DIAB      | Drug           | Clinical  | Industry  | Completed              | 3.0     | 4330            | 4500                 | US,AR,AU,BE,CA,CO,CZ,EE,FR,DE,HU,IN,IL,LU,MY,MX,NL,NZ,NO,PL,RU,ES,SE,UA,GB,BR,CZ                                     | 0.0         | 4330.0    | 1             | None                            | True         | ../data/ctgov/json/29_NCT01032629_Prot_000.pdf.json                                                                                                     | HIV                | 3.0           | 3            | 0           | 4500      | 1              | 0           | AU,GB,MX,SE,US,XX | 60           | LOW                 |
| NCT01107626 | LUNG      | Drug           | Clinical  | Other     | Active, Not Recruiting | 3.0     | 1516            | 1282                 | US                                                                                                                   | 1.0         | 1516.0    | 0             | Feasibility                     | True         | ../data/ctgov/json/26_NCT01107626_Prot_SAP_000.pdf.json                                                                                                 | HIV                | 3.0           | 1            | 1           | 878       | 1              | 0           | CA,US             | 62           | LOW                 |
| NCT01144338 | DIAB      | Drug           | Clinical  | Industry  | Completed              | 3.0     | 14752           | 9500                 | US,AR,AU,AT,BE,BR,BG,CA,CL,CN,CO,CZ,DE,HK,HU,IL,IT,KR,LV,LT,MY,MX,NL,NZ,PH,PL,RO,RU,SK,ZA,ES,TW,TH,UA,GB,CZ,FR,IN,PE | 0.0         | 14752.0   | 1             | None                            | True         | ../data/ctgov/json/38_NCT01144338_Prot_000.pdf.json                                                                                                     | Other              | 1.0           | 2            | 0           | 14000     | 1              | 0           | CA,US             | 48           | MEDIUM              |
| NCT01205776 | CVS       | Device         | Clinical  | Industry  | Completed              | nan     | 1905            | 2634                 | nan                                                                                                                  | nan         | nan       | 0             | Feasibility                     | True         | /media/thomas/642d0db5-2c98-4156-b591-1a3572c5868c/projects_client/clinical_trial_risk/validation/extra_data_hutchison/76_NCT01205776_Prot_000.pdf.json | Other              | 4.0           | 2            | 1           | 1900      | 1              | 1           | US                | 69           | LOW                 |
| NCT01206062 | CVS       | Other          | Clinical  | Other     | Completed              | nan     | 9361            | 9250                 | US                                                                                                                   | 0.0         | 9361.0    | 0             | Design                          | True         | ../data/ctgov/json/62_NCT01206062_Prot_000.pdf.json                                                                                                     | Other              | 0.0           | 2            | 1           | 9250      | 1              | 1           | US                | 69           | LOW                 |
|             |           |                |           |           |                        |         |                 |                      |                                                                                                                      |             |           |               |                                 |              |                                                                                                                                                         |                    |               |              |             |           |                |             |                   |              |                     |
| ACCURACY    |           |                |           |           |                        |         |                 |                      |                                                                                                                      |             |           |               |                                 |              |                                                                                                                                                         |                    | 0.5           |              |             |           |                |             |                   |              | 0.16666666666666666 |